Hologic completed the acquisition of Acessa Health for $80m.

Hologic, an innovative medical technology company primarily focused on improving women's health, completed the acquisition of Acessa Health, a women’s health innovator dedicated to advancing minimally invasive, uterine-sparing solutions for women with symptomatic fibroids, for $80m. “Acquiring Acessa Health strengthens our leadership position in the GYN surgical space and broadens our fibroid treatment portfolio with a highly complementary new product. Together with the Acessa team, we can leverage our core women's health expertise, commercial infrastructure and physician relationships to accelerate our growth strategy and offer superior technology that translates into better clinical outcomes for women,” Essex Mitchell, Hologic’s Division President, GYN Surgical Solutions.